Caughey G H, Leidig F, Viro N F, Nadel J A
Cardiovascular Research Institute, University of California, San Francisco.
J Pharmacol Exp Ther. 1988 Jan;244(1):133-7.
The peptides substance P (SP) and vasoactive intestinal peptide (VIP) released from peptidergic neurons have potent effects on gland secretion and on smooth muscle tone. Because mast cells release proteases during degranulation, and are located in many of the same tissue microenvironments into which SP and VIP are released, we wished to examine whether mast cell proteases, by cleaving and thus inactivating these peptides, could modulate their effects. We used active site-titrated preparations of the two major neutral proteases of mast cell granules, tryptase and chymase, to determine the sites and rates of cleavage of SP and VIP. The proteases were purified from dog mastocytomas. Tryptase cleaved VIP rapidly at two sites with a kcat/Km of 2.2 X 10(5) sec-1 M-1, but had no effect on SP. Chymase cleaved both SP and VIP at primarily a single site with kcat/Km of 3.9 X 10(4) and 5.4 X 10(4) sec-1 M-1, respectively. Thus, these data show that mast cell proteases degrade SP and VIP. The differences in peptidase activity between tryptase and chymase suggest that the consequences of protease release could vary according to mast cell protease phenotype and location in various tissues and species. Tryptase, by cleaving the bronchodilator VIP but not the bronchoconstrictor SP, might promote bronchial hyper-responsiveness in asthma by decreasing the nonadrenergic neural inhibitory influence mediated by VIP. In skin and other tissues, chymase might interrupt axon reflex-mediated neurogenic inflammation by cleaving SP.
从肽能神经元释放的P物质(SP)和血管活性肠肽(VIP)对腺体分泌和平滑肌张力有强大作用。由于肥大细胞在脱颗粒过程中释放蛋白酶,且位于许多与SP和VIP释放到相同的组织微环境中,我们希望研究肥大细胞蛋白酶是否通过切割并使这些肽失活来调节其作用。我们使用肥大细胞颗粒的两种主要中性蛋白酶——类胰蛋白酶和糜蛋白酶的活性位点滴定制剂,来确定SP和VIP的切割位点和速率。这些蛋白酶从犬肥大细胞瘤中纯化得到。类胰蛋白酶能迅速在两个位点切割VIP,催化常数与米氏常数的比值(kcat/Km)为2.2×10⁵秒⁻¹·M⁻¹,但对SP无作用。糜蛋白酶主要在一个位点切割SP和VIP,kcat/Km分别为3.9×¹⁰⁴和5.4×10⁴秒⁻¹·M⁻¹。因此,这些数据表明肥大细胞蛋白酶可降解SP和VIP。类胰蛋白酶和糜蛋白酶在肽酶活性上的差异表明,蛋白酶释放的后果可能因肥大细胞蛋白酶表型以及在不同组织和物种中的位置而异。类胰蛋白酶通过切割支气管扩张剂VIP而非支气管收缩剂SP,可能通过减少VIP介导的非肾上腺素能神经抑制作用来促进哮喘中的支气管高反应性。在皮肤和其他组织中,糜蛋白酶可能通过切割SP来中断轴突反射介导的神经源性炎症。